Prospects for understanding and eliminating the deleterious effects of cardiopulmonary bypass
- 30 April 1991
- journal article
- editorial
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 51 (4) , 529-531
- https://doi.org/10.1016/0003-4975(91)90302-7
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Membrane oxygenator prevents lung reperfusion injury in canine cardiopulmonary bypassThe Annals of Thoracic Surgery, 1991
- High-Dose Aprotinin: Hemostatic Effects in Open Heart OperationsThe Annals of Thoracic Surgery, 1989
- Complement Activation in Cardiopulmonary Bypass, with Special Reference to Anaphylatoxin Production in Membrane and Bubble OxygenatorsThe Annals of Thoracic Surgery, 1988
- Deposition of Terminal C5b–9 Complement Complexes on Erythrocytes and Leukocytes during Cardiopulmonary BypassNew England Journal of Medicine, 1988
- Effects of Protamine Administration after Cardiopulmonary Bypass on Complement, Blood Elements, and the Hemodynamic StateThe Annals of Thoracic Surgery, 1986
- Adult Respiratory-Distress SyndromeNew England Journal of Medicine, 1982
- Complement Activation during Cardiopulmonary BypassNew England Journal of Medicine, 1981
- On the reaction of plasmin or plasmin-streptokinase complex with aprotinin or α2-antiplasminThrombosis Research, 1979
- Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes.Journal of Clinical Investigation, 1977
- Complement and Leukocyte-Mediated Pulmonary Dysfunction in HemodialysisNew England Journal of Medicine, 1977